ABCB1 p.Gln132Arg
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 21177413
[PubMed]
Parveen Z et al: "Molecular dissection of dual pseudosymmetric solute translocation pathways in human P-glycoprotein."
No.
Sentence
Comment
52
Site-directed mutagenesis was performed at positions 132 and 773 of hexahistidine-tagged human P-gp cloned into the entry vector pENTR4-MDR1-His6 to generate the Q132A, Q132R, Q773A, Q773R, and the Q132A/Q773A mutants using the following forward and reverse primers: Q132A: forward, 5Ј-CTG CTT ACA TTG CGG TTT CAT TTT GG-3Ј; reverse, 5Ј-CCA AAA TGA AAC CGC AAT GTA AGC AG-3Ј; Q132R: forward, 5Ј-GCT GCT TAC ATT CGT GTT TCA TTT TG-3Ј; reverse, 5Ј-CAA AAT GAA ACA CGA ATG TAA GCA GC-3Ј; Q773A: forward, 5Ј-CAT TTT TCC TTG CGG GTT TCA CAT TTG GC-3Ј; reverse, 5Ј-GCC AAA TGT GAA ACC CGC AAG GAA AAA TG-3Ј; Q773R: forward, 5Ј-CAT TTT TCC TTC GAG GTT TCA CAT TTG-3Ј; reverse, 5Ј-CAT TTT TCC TTC GAG GTT TCA CAT TTG-3Ј.
X
ABCB1 p.Gln132Arg 21177413:52:169
status: NEWX
ABCB1 p.Gln132Arg 21177413:52:400
status: NEW53 Double mutant Q132R/Q773R was generated by restriction digestion of pENTR4-Q132R and pENTR4-Q773R with SalI and EcoRI and subsequent ligation of the mutated fragment from pENTR4-Q773R into pENTR4-Q132R using T4 DNA ligase (rapid DNA ligation kit; Fermentas, Vienna, Austria).
X
ABCB1 p.Gln132Arg 21177413:53:14
status: NEWX
ABCB1 p.Gln132Arg 21177413:53:75
status: NEWX
ABCB1 p.Gln132Arg 21177413:53:196
status: NEW137 Rhodamine123 Efflux in Q132R/A and Q773R/A Mutants.
X
ABCB1 p.Gln132Arg 21177413:137:23
status: NEW138 In an initial series of experiments, we monitored rhodamine123 efflux in HEK-293/EBNA cells transiently transfected with either wild-type P-gp or the Q132R and Q773R mutants.
X
ABCB1 p.Gln132Arg 21177413:138:150
status: NEW161 Effect of Propafenone Analogs on Rhodamine123 Efflux in Q132R/A and Q773R/A Mutants.
X
ABCB1 p.Gln132Arg 21177413:161:56
status: NEW172 The IC50 value for wild-type P-gp was found to be 0.11 Ϯ 0.06 M (black), whereas mutant Q132R showed an almost 7-fold higher IC50 value of 0.71 Ϯ 0.46 M (green).
X
ABCB1 p.Gln132Arg 21177413:172:102
status: NEW177 IC50 values for wild type (black) and mutants Q132R (green) and Q773R (orange) (Fig. 5, Table 2) were indistinguishable, demonstrating that uncharged P-gp solutes were not affected by introduction of a positive charge in either position 132 or 773.
X
ABCB1 p.Gln132Arg 21177413:177:46
status: NEW181 Effect of Verapamil and Vinblastine on Rhodamine123 Efflux in Q132R/A and Q773R/A Mutants.
X
ABCB1 p.Gln132Arg 21177413:181:62
status: NEW182 In a third series of experiments, we evaluated the effect of verapamil and vinblastine on rhodamine123 transport in wild type and mutants Q132R and Q773R.
X
ABCB1 p.Gln132Arg 21177413:182:138
status: NEW200 In contrast, the IC50 values for the Q132R and Q773R mutants were 1.24 Ϯ 0.13 and 0.14 Ϯ 0.04 M, respectively.
X
ABCB1 p.Gln132Arg 21177413:200:37
status: NEW202 The respective IC50 values were 2.68 Ϯ 0.93 M for wild type, 0.45 Ϯ 0.16 M for mutant Q773R, and 9.19 Ϯ 1.2 M for the Q132R mutant.
X
ABCB1 p.Gln132Arg 21177413:202:160
status: NEW232 Q132R (green) and Q773R (orange) show transport rates of 52 Ϯ 13 and 24 Ϯ 6% of wild type, respectively (error propagation accounted for).
X
ABCB1 p.Gln132Arg 21177413:232:0
status: NEW233 The double mutant Q132R/Q773R (cyan) shows flux rates that are equal to simple diffusion (0.7-0.8/s).
X
ABCB1 p.Gln132Arg 21177413:233:18
status: NEW246 Both the Q132R and the Q773R mutant showed reduced transport activity for rhodamine123, which, however, was more pronounced in the Q773R mutant.
X
ABCB1 p.Gln132Arg 21177413:246:9
status: NEW265 Wild-type P-gp, black curve; Q132R, green curve; Q773R, orange curve.
X
ABCB1 p.Gln132Arg 21177413:265:29
status: NEW285 Wild-type P-gp, black curve; Q132R, green curve; Q773R, orange curve.
X
ABCB1 p.Gln132Arg 21177413:285:29
status: NEW289 Black curve, wild-type P-gp; green curve, Q132R; orange curve, Q773R.
X
ABCB1 p.Gln132Arg 21177413:289:42
status: NEW295 Black curve, wild-type P-gp; green curve, Q132R; orange curve, Q773R.
X
ABCB1 p.Gln132Arg 21177413:295:42
status: NEW299 Mutation IC50 Verapamil Vinblastine GPV31 GPV366 M Wild-type P-gp 0.43 Ϯ 0.10 2.68 Ϯ 0.93 0.11 Ϯ 0.06 2.60 Ϯ 0.69 Q132A 0.30 Ϯ 0.07 2.58 Ϯ 0.31 0.10 Ϯ 0.03 2.57 Ϯ 0.69 Q773A 0.42 Ϯ 0.15 2.80 Ϯ 0.12 0.11 Ϯ 0.05 2.40 Ϯ 1.47 Q132A/Q773A 0.44 Ϯ 0.16 2.24 Ϯ 0.43 0.12 Ϯ 0.01 2.87 Ϯ 0.63 Q132R 1.24 Ϯ 0.13* 9.19 Ϯ 1.20* 0.71 Ϯ 0.46* 2.64 Ϯ 0.59 Q773R 0.14 Ϯ 0.04* 0.45 Ϯ 0.16* 0.02 Ϯ 0.01* 2.09 Ϯ 0.90 * P Ͻ 0.05, significantly different from wild-type values.
X
ABCB1 p.Gln132Arg 21177413:299:386
status: NEW
PMID: 24366667
[PubMed]
Donmez Cakil Y et al: "Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs."
No.
Sentence
Comment
54
Furthermore, Q132R and Q773R mutations were introduced to the constructs above by using the following: Q132R- forward, 59-GCTGCTTACATTCGTGTTTCATTTTG-39; Q132R-reverse, 59- CAAAATGAAACACGAATGTAAGCAGC-39; Q773R-forward, 59-CAT TTTTCCTTCGAGGTTTCACATTTG-39; and Q773R-reverse, 59-CA TTTTTCCTTCGAGGTTTCACATTTG-39.
X
ABCB1 p.Gln132Arg 24366667:54:13
status: NEWX
ABCB1 p.Gln132Arg 24366667:54:103
status: NEWX
ABCB1 p.Gln132Arg 24366667:54:153
status: NEW114 All mutants were detected at the plasma membrane, although the expression levels of Q132R/Y950F, Q773R/Y950F, and Y307F/Y310F were reduced (Supplemental Fig. 5).
X
ABCB1 p.Gln132Arg 24366667:114:84
status: NEW120 Access of rh123 to binding sites 1 and 2 can be controlled by the introduction of positive charges (arginines) in the access path to the ligand binding sites. We previously showed that the Q132R mutation blocks access to site 2 for rh123, whereas the Q773R mutation prevents rh123 access to site 1 (Parveen et al., 2011).
X
ABCB1 p.Gln132Arg 24366667:120:189
status: NEW125 This is illustrated by comparable transport activity of the Q132R/Y950F, Q132R/Y953F, and Q132R/ Y950F/Y953F mutants.
X
ABCB1 p.Gln132Arg 24366667:125:60
status: NEWX
ABCB1 p.Gln132Arg 24366667:125:73
status: NEWX
ABCB1 p.Gln132Arg 24366667:125:90
status: NEW155 The at least 3-fold difference in IC50 values for wild-type protein (GPV005, 518 6 141 nM; and GPV031, 85 6 22 nM) (Fig. 3, B and C) and the Q132R mutant (GPV005, 1414 6 215 nM; and GPV031, 521 6 183 nM) (Fig. 4, A and B) demonstrates that an arginine residue in position 132 prevents access of protonatable compounds to site 2.
X
ABCB1 p.Gln132Arg 24366667:155:141
status: NEW163 show that for the Q132R/Y950F mutant, IC50 values were similar to those observed in the Q132R background alone.
X
ABCB1 p.Gln132Arg 24366667:163:18
status: NEWX
ABCB1 p.Gln132Arg 24366667:163:88
status: NEW164 However, IC50 values were still higher in the Q132R/Y953F mutation.
X
ABCB1 p.Gln132Arg 24366667:164:46
status: NEW168 For the nonprotonatable acid amide GPV366, a higher IC50 value was observed in the Q132R/Y953F mutant (Q132R, 1074 6 282 nM; and Q132R/Y953F, 3261 6 965 nM), whereas the Y950F mutation in the same background did not affect potency (966 6 259 nM) (Fig. 4C).
X
ABCB1 p.Gln132Arg 24366667:168:83
status: NEWX
ABCB1 p.Gln132Arg 24366667:168:103
status: NEWX
ABCB1 p.Gln132Arg 24366667:168:129
status: NEW169 Although the pattern was similar to that observed in the wild-type background, the fold change was lower in the Q132R background and the IC50 value was somewhat lower in the protein containing the Q132R mutation than for wild-type.
X
ABCB1 p.Gln132Arg 24366667:169:112
status: NEWX
ABCB1 p.Gln132Arg 24366667:169:197
status: NEW170 A possible explanation for this effect is the lack of competition of GPV366 in the preferred binding site 2 with rh123, because rh123 binding to site 2 is abolished by the Q132R mutation.
X
ABCB1 p.Gln132Arg 24366667:170:172
status: NEW171 The higher IC50 values in the Q132R/Y950F/Y953F mutant were not due to an additive effect of the two tyrosine mutations on binding of propafenones.
X
ABCB1 p.Gln132Arg 24366667:171:30
status: NEW173 Certainly, the effect is not brought about by a global perturbance of protein structure and function, because the Q132R mutant and the Q132R/Y950F/Y953F triple mutant showed comparable rh123 transport rates (Fig. 2).
X
ABCB1 p.Gln132Arg 24366667:173:114
status: NEWX
ABCB1 p.Gln132Arg 24366667:173:135
status: NEW189 The tyrosine mutants were generated in the Q132R mutation background.
X
ABCB1 p.Gln132Arg 24366667:189:43
status: NEW191 *P , 0.05; **P , 0.01; ***P , 0.001, compared with Q132R mutation.
X
ABCB1 p.Gln132Arg 24366667:191:51
status: NEW193 Identical transport rates were found for the Q132R and the Y953F mutants in the Q132R background.
X
ABCB1 p.Gln132Arg 24366667:193:45
status: NEWX
ABCB1 p.Gln132Arg 24366667:193:80
status: NEW200 IC50 values were therefore expected to be the same in single and double tyrosine mutants generated in the Q132R background.
X
ABCB1 p.Gln132Arg 24366667:200:106
status: NEW201 Indeed, no difference was observed between the Q132R single mutant and the Q132R/Y950F double mutant.
X
ABCB1 p.Gln132Arg 24366667:201:47
status: NEWX
ABCB1 p.Gln132Arg 24366667:201:75
status: NEW205 The uncharged ligand species can still have access to site 2, which has been deselected for the protonated ligand species by introducing the Q132R mutation.
X
ABCB1 p.Gln132Arg 24366667:205:141
status: NEW212 For GPV005, mutant Q132R/Y953F showed a 1.5-fold higher IC50 value than the Q132R mutation, whereas the fold changes were 2.1-fold for GPV031 and 3.0-fold for uncharged GPV366.
X
ABCB1 p.Gln132Arg 24366667:212:19
status: NEWX
ABCB1 p.Gln132Arg 24366667:212:76
status: NEW214 However, such an effect was not observed in the Q132R background (Fig. 4, A and B).
X
ABCB1 p.Gln132Arg 24366667:214:48
status: NEW217 The triple Q132R/Y950F/Y953F mutant showed a further increase in IC50 values for all compounds, which is obviously not due to interaction with tyrosines.
X
ABCB1 p.Gln132Arg 24366667:217:11
status: NEW
PMID: 25016028
[PubMed]
Zolnerciks JK et al: "The Q loops of the human multidrug resistance transporter ABCB1 are necessary to couple drug binding to the ATP catalytic cycle."
No.
Sentence
Comment
74
Plasmids Mutations were introduced into a plasmid encoding human ABCB1 with a C-terminal hexahistidine tag (pCIneo-wtABCB1-6His; ref. 25) by site-directed mutagenesis (QuikChange XL; Stratagene, La Jolla, CA, USA) using the following oligonucleotides: Q132A, 5=-GGTTGCTGCTTACATCGCGGTTTCATTTTGGTGC- 3=; Q132R, 5=-GGTTGCTGCTTACATTCGAGTTTCATTTTG- GTGC-3=; Q475A, 5=-GGGAAATCATTGGTGTGGTGAGTGCT- GAGCCTGTATTGTTTGCCACCACG-3=; Q773A, 5=-GGAATTA- TTTCTTTTATTACATTTTTCCTTGCGGGTTTCACATTTG- GCAAAGCTGG-3=; Q773R, 5=-GGAATTATTTCTTTTATTA- CATTTTTCCTTCGAGGTTTCACATTTGGCAAAGCTGG-3=; Q1118A, 5=-GGGCATCGTGTCCGCGGAACCCATCCTGTTTG-3=; E556Q, 5=-CCCCAAGATCCTCCTGCTTGATCAGGCCACGT- CAGCCTTGG-3=; and E1201Q, 5=-CAGCCTCATATTTTGCTTCT- TGATCAGGCCACGTCAGCTCTGGATAC-3=.
X
ABCB1 p.Gln132Arg 25016028:74:302
status: NEW207 The single mutant TMD1-Q132R effluxed the Bodipy-verapamil with 70% efficiency of the wild-type protein, whereas the TMD2- Q773R was fully active and indistinguishable from wild-type ABCB1 (Fig. 6, dark gray bars, in which transport data are presented as the fold reduction in Bodipy-verapamil accumulation compared to mock-transfected cells).
X
ABCB1 p.Gln132Arg 25016028:207:23
status: NEW209 The double-arginine mutant Q132R/ Q773R retained the ability to export Bodipy-verapamil, but it was significantly reduced to 42% (Pb0d;0.001) of wild-type ABCB1 activity.
X
ABCB1 p.Gln132Arg 25016028:209:27
status: NEW210 This residual activity is most likely due to the partial masking of the positive charge on verapamil by the Bodipy moiety, such that electrostatic repulsion from Q132R or Q773R is incomplete.
X
ABCB1 p.Gln132Arg 25016028:210:162
status: NEW212 To test whether each verapamil-binding cavity was coupled to the NBDs via a specific Q loop, we combined the single drug cavity mutants TMD1-Q132R and TMD2- Q773R with the NBD Q-loop mutants NBD1-Q475A and NBD2-Q1118A and compared their transport activity (Fig. 6, striped bars) with that of the drug cavity mutants and also the single-and double-Q-loop mutants (Fig. 6, light gray bars; note that the double-Q-loop mutant has a fold difference that is b0d;1 because it provides additional binding sites for Bodipy-verapamil in the membrane).
X
ABCB1 p.Gln132Arg 25016028:212:141
status: NEW213 The drug cavity mutant TMD1-Q132R combined synergistically with NBD1-Q475A to significantly reduce Bodipy-verapamil export activity to 25% of wild-type activity, but in combination with NBD2-Q1118A, the transporter retained the full level of activity of each single mutant.
X
ABCB1 p.Gln132Arg 25016028:213:28
status: NEW214 (At 85% of the wild type, this activity was not significantly different from that of the Q132R mutant or the Q1118A mutant.)
X
ABCB1 p.Gln132Arg 25016028:214:89
status: NEW215 This observation shows that the wild-type Q773- lined verapamil-binding cavity of the Q132R mutant is dedicated to, and only requires, the NBD1 Q loop to couple to the ATP catalytic cycle.
X
ABCB1 p.Gln132Arg 25016028:215:86
status: NEW224 The single-Q-loop mutants, combined with the TMD mutants Q132R in TMD1 or Q773R in TMD2 that line the 2 verapamil-binding cavities (12), showed that Bodipy-verapamil bound to the cavity lined by TMD2-Q773 triggers conformation change to the inward-closed state via the conduit of the Q loop in NBD1.
X
ABCB1 p.Gln132Arg 25016028:224:57
status: NEW